Imed Infinity Medical-Limited Partnership
Tel Aviv Stock Exchange IMED.TA
Imed Infinity Medical-Limited Partnership Gross Profit for the year ending December 31, 2023
Imed Infinity Medical-Limited Partnership Gross Profit is NA for the year ending December 31, 2023. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
-
Imed Infinity Medical-Limited Partnership Gross Profit for the year ending December 31, 2022 was USD 200.00 K, a 166.67% change year over year.
-
Imed Infinity Medical-Limited Partnership Gross Profit for the year ending December 31, 2021 was USD 75.00 K.
Key data
| Date | Gross Profit | Operating Income | EBIT | EBITDA |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: IMED.TA
| CEO | Mr. Itay Gal-Or |
| IPO Date | Jan. 4, 2021 |
| Location | Israel |
| Headquarters | Azrieli Tower |
| Employees | 55 |
| Sector | Industrials |
| Industries | |
Description
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. The company was incorporated in 2020 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email